News
The US Food and Drug Administration has issued emergency use authorization (EUA) for the Covid-19 vaccine developed by Pfizer and BioNTech.
A Turkish study finds Pfizer’s COVID-19 vaccine may cause temporary changes in corneal thickness and cell count, raising concerns for those with existing eye issues or transplants.
Turkish scientists say that Pfizer's COVID-19 vaccine can increase the risk of eye damage, causing vision loss. A new study ...
4d
Health and Me on MSNPfizer COVID-19 Vaccine Linked To Major Eye Dysfunction, Study FindsA new study suggests a potential link between the Pfizer COVID-19 vaccine and serious eye conditions like retinal vascular ...
3d
TheHealthSite on MSNPfizer-BioNTech's COVID-19 Vaccine: What Does A Thicker Cornea And Reduced Cell Density Mean?BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...
It's important to note, however, that Pfizer's vaccine requires two doses administered several weeks apart to reach 95% efficacy. So 100 million doses would vaccinate half the number of people.
Pfizer's vaccine has no major safety concerns but can cause temporary side effects like pain at the injection site, fatigue, and headaches. Business Insider Subscribe Newsletters ...
Pfizer's COVID-19 vaccine had side effects that were 'worse than I thought,' volunteer tells 'Fox & Friends' By Caleb Parke Fox News. Published November 12, 2020 8:41am EST. ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results